Emedastine is an antihistamine compound primarily used in ophthalmic formulations for the treatment of allergic conjunctivitis. It functions as a selective H1 receptor antagonist, effectively blocking the action of histamine, which is responsible for allergy symptoms. Emedastine is characterized by its ability to alleviate itching, redness, and swelling in the eyes caused by allergens. The substance is typically administered as eye drops, allowing for localized action with minimal systemic absorption. Its chemical structure includes a piperidine ring, contributing to its pharmacological properties. Emedastine is generally well-tolerated, with a low incidence of side effects, although some patients may experience mild ocular irritation. The compound is soluble in water, which facilitates its formulation in aqueous solutions for ophthalmic use. Overall, Emedastine represents a targeted approach to managing allergic reactions in the eyes, providing relief for individuals suffering from seasonal or perennial allergic conjunctivitis.

Emedastine

87233-61-2: 1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole, 1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H-benzimidazole, 1-Methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepane, 1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole, 1H-1,4-Diazepine, 1H-benzimidazole deriv., 1H-benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-, 87233-61-2, Rapimine, Emedastine

CAS 87233-61-2: Emedastine

Emedastine

Ref: 54-BUP12870

Emedastine-13C-d3 Fumarate

Ref: 4Z-E-343

Emedastine

Ref: 4Z-E-3414

Emedastine

Ref: IN-DA00GRJ2